Cargando…
Clinical deterioration during antituberculosis treatment in Africa: Incidence, causes and risk factors
BACKGROUND: HIV-1 and Mycobacterium tuberculosis cause substantial morbidity and mortality. Despite the availability of antiretroviral and antituberculosis treatment in Africa, clinical deterioration during antituberculosis treatment remains a frequent reason for hospital admission. We therefore det...
Autores principales: | Pepper, Dominique J, Marais, Suzaan, Wilkinson, Robert J, Bhaijee, Feriyl, Maartens, Gary, McIlleron, Helen, De Azevedo, Virginia, Cox, Helen, McDermid, Cheryl, Sokhela, Simiso, Patel, Janisha, Meintjes, Graeme |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858733/ https://www.ncbi.nlm.nih.gov/pubmed/20353569 http://dx.doi.org/10.1186/1471-2334-10-83 |
Ejemplares similares
-
Barriers to Initiation of Antiretrovirals during Antituberculosis
Therapy in Africa
por: Pepper, Dominique J., et al.
Publicado: (2011) -
Assessment at Antiretroviral Clinics during TB Treatment Reduces Loss to Follow-Up among HIV-Infected Patients
por: Pepper, Dominique J., et al.
Publicado: (2012) -
Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus‐associated tuberculosis
por: Schutz, Charlotte, et al.
Publicado: (2020) -
Current research toward optimizing dosing of first-line antituberculosis treatment
por: McIlleron, Helen, et al.
Publicado: (2018) -
Inflammasome Activation Underlying Central Nervous System Deterioration in HIV-Associated Tuberculosis
por: Marais, Suzaan, et al.
Publicado: (2017)